Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

AllinMD Closes $100 Million Series B for Online/Hospital Orthopedic Services

publication date: Sep 20, 2019

AllinMD Orthopedics Hospital of Beijing closed a $100 million Series B round to build its combination of orthopedic hospitals and internet medical care. The round was led by Sheares, a medical care fund of Singapore's sovereign wealth fund Temasek, and H Capital, a US venture capital firm. Tencent and Trustbridge Partners also participated. AllinMD will use the capital to increase the number of its physical hospitals while also expanding its online education services to more orthopedic doctors in China’s smaller cities and rural areas. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022